Mesoblast and Tasly Pharmaceutical Group Complete Transaction for Strategic Cardiovascular Partnership in China

World News: . []

NEW YORK and MELBOURNE Australia Oct 12 2018 GLOBE NEWSWIRE) -- Mesoblast Limited NasdaqMESO ASX:MSB) today announced completion of the transaction with Tasly Pharmaceutical Group to establish a strategic partnership in China for Mesoblast ’s al...

More news and information about Mesoblast Limited

Published By:

Globe Newswire: 11:00 GMT Friday 12th October 2018

Published: .

Search for other references to "mesoblast" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us